Tresiba FlexTouch Insulin Degludec Pen – Ultra Long-Acting Insulin for Diabetes Management

Tresiba FlexTouch Insulin Degludec Pen contains Insulin Degludec, an ultra-long-acting basal insulin used to improve blood sugar control in adults and children with diabetes mellitus. It provides a steady and prolonged insulin release, helping maintain stable blood glucose levels throughout the day and night with a duration of action exceeding 24 hours. The FlexTouch pre-filled pen is designed for convenient and accurate insulin administration. Its easy-to-use dosing mechanism helps patients deliver the prescribed dose with confidence while supporting consistent diabetes management. Tresiba is commonly used as part of a comprehensive diabetes treatment plan that includes a balanced diet, regular physical activity, and routine blood glucose monitoring. It may be prescribed alone or in combination with other diabetes medications as directed by a healthcare professional.

Key Features

Ultra Long-Acting Insulin: Provides continuous blood glucose control for more than 24 hours.
Flexible Dosing Schedule: Offers flexibility in administration timing when prescribed.
Pre-Filled FlexTouch Pen: Designed for easy and accurate dose delivery.
Supports Stable Blood Sugar Levels: Helps reduce fluctuations in glucose levels.
Suitable for Type 1 & Type 2 Diabetes: Used as a basal insulin therapy.

Key Ingredient

Insulin Degludec: An ultra long-acting insulin analog that helps regulate blood glucose levels.

How to Use

Use exactly as prescribed by your healthcare professional.
Administer as a subcutaneous injection in the abdomen, thigh, or upper arm.
Rotate injection sites regularly to reduce the risk of skin-related complications.
Use a new sterile needle for each injection.
Monitor blood glucose levels regularly as advised by your doctor.
Do not change the dose without medical guidance.

Precautions

Use only under medical supervision.
Do not share the pen device with other individuals.
Store unopened pens in a refrigerator at 2°C–8°C.
Do not freeze or expose the insulin to excessive heat.
Inform your healthcare provider about any kidney, liver, or heart conditions.

Warning

May cause hypoglycemia (low blood sugar), which can be serious if untreated.
Common side effects may include injection site reactions, swelling, itching, or weight gain.
Seek immediate medical attention if severe allergic reactions occur.
Keep out of reach of children.

Legal Disclaimer: Tresiba FlexTouch Insulin Degludec Pen is a prescription medication intended for the management of diabetes mellitus. Use only under the supervision of a qualified healthcare professional. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.